NCT05701930

Brief Summary

Cancer; It is defined as a large group of diseases that can start in any organ or tissue of the body, occur with the uncontrolled growth of abnormal cells, and occur when these abnormal cells go beyond their normal limits and spread to neighboring tissues and other organs. The leading goal of cancer treatment is to eradicate the cancer. Cancer treatments are divided into two basic groups as local and systemic.Systemic treatments include chemotherapy, hormone therapy, targeted molecular therapy, and immunotherapy. The use of drugs that slow down, control, stop and destroy cancer cells in the treatment are called chemotherapy, and the drugs used for this purpose are called chemotherapeutics (cytostatics) or antineoplastic drugs. Quality of life is personal well-being and is an expression of subjective satisfaction in different areas of life. This concept includes family, work life and socio-economic conditions. It includes the difference between the ideals, expectations and dreams of individuals and the reality, that is, the perception of satisfaction and well-being that the individual receives from his daily life. In the medical field, it is the expression of the individual's physical, emotional and social well-being. The symptoms that cancer patients encounter both in cancer and in the treatment process affect the quality of life of the patient and cause the treatment to be interrupted. Therefore, symptom management is very important in order not to hinder treatment and to stop the risk of morbidity and mortality. Most of the symptoms of advanced cancer patients can be managed with pharmacological or non-pharmacological methods, and this management is an expected skill for all clinicians who take care of patients with cancer. Pecha Kucha (PK), meaning "chat voice" or "chat" in Japanese, refers to a well-crafted, fast and concise presentation format. In a PK presentation, each presenter is only allowed to show 20 PowerPoint slides for 20 seconds each on a timer. In other words, the presenter has only 20 seconds to discuss each slide before the next slide appears, and the presentation time is limited to 6 minutes and 40 seconds. Ideas are explained visually with pictures and graphics, and there is little text on the slides.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 18, 2023

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

January 19, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 27, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 20, 2023

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 25, 2024

Completed
Last Updated

January 31, 2024

Status Verified

January 1, 2024

Enrollment Period

4 months

First QC Date

January 19, 2023

Last Update Submit

January 30, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Edmonton Symptom Diagnostic Scale

    It was developed to evaluate nine symptoms seen in cancer patients. The scale includes pain, fatigue, nausea, sadness, anxiety, insomnia, loss of appetite, well-being and shortness of breath. In scale; The severity of each symptom is evaluated with numerical scores from 0 to 10. The most important rule in the evaluation of the symptom is to mark the number indicating the severity of the symptom according to the patient's own expression. The patient is asked to match the symptoms he or she is experiencing with a number from 0 to 10 that he thinks is most suitable for him. A score of 0 in the scale indicates the absence of symptoms, while a score of 10 indicates that the symptom is experienced very severely.

    1 hours

  • EORTC QLQ-C 30 Quality of Life Scale

    This scale was developed by the European cancer treatment and research organization in 1987 to evaluate the quality of life of patients with cancer.

    1 hours

Study Arms (2)

Experimental:

EXPERIMENTAL

pecha kucha will be practiced

Behavioral: symptom management

control

NO INTERVENTION

Routine maintenance will be applied.

Interventions

pecha kucha training

Also known as: life quality
Experimental:

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being 18 years or older,
  • Not having a verbal communication disability (hearing and speaking),
  • Being a Cancer Patient in the second or third stage

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gülcan B.Turan

Elâzığ, Merkez, 23000, Turkey (Türkiye)

RECRUITING

MeSH Terms

Interventions

Palliative CareQuality of Life

Intervention Hierarchy (Ancestors)

Patient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and ServicesHealth StatusDemographyEpidemiologic MeasurementsPublic HealthEnvironment and Public Health

Central Study Contacts

Gülcan B.TURAN, PHD

CONTACT

Fatma Gürcan, STD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Single (Participant) symptom management, life quality
Purpose
SUPPORTIVE CARE
Intervention Model
SEQUENTIAL
Model Details: pecha kucha training
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 19, 2023

First Posted

January 27, 2023

Study Start

January 18, 2023

Primary Completion

May 20, 2023

Study Completion

February 25, 2024

Last Updated

January 31, 2024

Record last verified: 2024-01

Locations